🔥 Trending Canada Approves First Generic Weight-Loss Injection

Generic Wegovy in Canada refers to generic versions of semaglutide, a medication originally marketed under the brand name Wegovy, which is used for chronic weight management. Health Canada has recently approved the first generic semaglutide for this purpose, making it available to Canadians ²⁵⁶.

Understanding Generic Wegovy

What is Semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by mimicking a natural hormone in the body that targets areas of the brain involved in appetite regulation. This helps to reduce appetite, increase feelings of fullness, and slow down gastric emptying, leading to reduced calorie intake and weight loss ¹.

Brand Name vs. Generic

Wegovy is the brand-name version of semaglutide, developed by Novo Nordisk, specifically approved for weight management ¹. A generic version, like Sevmia from Apotex, contains the exact same active pharmaceutical ingredient (semaglutide) in the same dosage and form as the brand-name drug. Generic drugs are required to demonstrate bioequivalence to their brand-name counterparts, meaning they work in the same way and provide the same clinical benefit ²⁷.

Approval and Availability in Canada

Health Canada Approval

Health Canada authorized the first generic semaglutide injection for weight loss on June 29, 2026 ⁴⁵. This approval came after a thorough review of evidence provided by the manufacturer, Apotex, demonstrating that the drug meets Health Canada's criteria for safety, efficacy, and quality ²⁵. The generic version is known as Sevmia ²⁴⁵.

Launch and Pricing

Generic semaglutide, including Apotex's version, began to launch in Canadian pharmacies in May 2026 ⁸. Early reports indicate that generic semaglutide from manufacturers like Apotex and Dr. Reddy's could be available for approximately $88 per month at pharmacies such as Costco ⁸. While the official pricing for Sevmia has not yet been published, the introduction of generic versions is expected to make semaglutide more accessible and affordable for patients ⁴.

Benefits of Generic Wegovy

Increased Accessibility

The approval of generic Wegovy is a significant development for Canadians struggling with obesity. Brand-name medications can often be expensive, posing a barrier to access for many. Generic versions typically offer a more affordable alternative, making the treatment more accessible to a wider population ¹⁸.

Cost Savings

Generic drugs are generally less expensive than their brand-name counterparts because generic manufacturers do not incur the initial research and development costs ¹. This cost saving can be substantial for patients, especially for long-term treatments like weight management.

Bioequivalence

Patients can be confident that generic semaglutide provides the same therapeutic effects as brand-name Wegovy. Health Canada's approval process ensures that generic drugs are bioequivalent, meaning they deliver the same amount of active ingredient to the bloodstream over the same period, thus having the same effect ⁷.